CLINICAL_TRIALS
trial_result
· 2013-10-08
Clinical Trial Update: Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma [Phase 2]
Summary
A Phase 2 clinical trial evaluating fenretinide in children with recurrent or resistant neuroblastoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Neuroblastoma | Phase 2 | Status: COMPLETED